0 Komentáře
0 Sdílení
325 Shlédnutí
0 Hodnocení
Hledat
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Global Doripenem Market to Reach USD 680 Million by 2034 Amid Rising Antibiotic Resistance and Hospital-Acquired InfectionsAccording to a new report from Intel Market Research, the global Doripenem market was valued at USD 450 million in 2024 and is projected to reach USD 680 million by 2034, growing at a steady CAGR of 4.1% during the forecast period (2025–2034). This growth stems from escalating antibiotic resistance and increasing prevalence of hospital-acquired infections requiring last-resort...0 Komentáře 0 Sdílení 297 Shlédnutí 0 Hodnocení
-
Global Ataxia Market Strategic Analysis and Industry ForecastThe Global Ataxia Market Size Was Valued at USD 23.12 Billion in 2023 and is Projected to Reach USD 37.43 Billion by 2032, Growing at a CAGR of 5.50% From 2024-2032. Ataxia is a neurological sign consisting of a lack of voluntary coordination of muscle movements that can include gait abnormality, speech changes, and abnormalities in eye movements. The ataxia market focuses on the development...0 Komentáře 0 Sdílení 2K Shlédnutí 0 Hodnocení
-
Global Multiple Drug Resistance Bacterial Infection Treatment Market Share Analysis by Geography – Industry Forecast to 2031The global Multiple Drug Resistance Bacterial Infection Treatment Market is becoming increasingly vital as the incidence of antimicrobial resistance (AMR) escalates across the world. Multidrug‑resistant (MDR) bacterial infections represent a critical public health threat, with resistant pathogens such as Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii reducing the...0 Komentáře 0 Sdílení 301 Shlédnutí 0 Hodnocení
-
Global Neomycin Market Set to Reach USD 620 Million by 2034 Amid Rising Infection BurdenAccording to a new report from Intel Market Research, the global Neomycin market was valued at USD 420 million in 2025 and is projected to reach USD 620 million by 2034, growing at a steady CAGR of 4.1% during the forecast period (2026–2034). This growth is fueled by rising antibiotic demand in human healthcare and veterinary medicine, coupled with increasing prevalence of bacterial...0 Komentáře 0 Sdílení 195 Shlédnutí 0 Hodnocení